Gabriela Burian

Burian joined Novaliq in 2017. With over 25 years of international clinical experience, she specializes in the field of clinical research and drug development in ophthalmology, with particular interest in clinical translation and biological markers.

Previously she held various leadership positions including Global Program Medical Director at Novartis Pharma and Ophthalmology Early Program Leader at F. Hoffmann-La Roche. Based in Basel, Switzerland, she founded and directs GB Biomed Advisors GmbH and provides clinical development strategic advice to ophthalmological startup projects around the world. She also currently serves as CMO of Iconic Therapeutics, Inc. (San Francisco, CA, USA) and is a faculty member of the European School for Advanced Studies in Ophthalmology (ESASO, Lugano, Switzerland).

Gabriela Burian is the Chief Medical Officer at Iconic Therapeutics, based in Switzerland, Europe. With a background in Biotechnology, Gabriela Burian has a rich history of leadership and innovation.Gabriela Burian studied MPH Epidemiology at Rollins School of Public Health - Emory University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.